Carisma Therapeutics
CARM
CARM
35 hedge funds and large institutions have $1.56M invested in Carisma Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
5
Increased
4
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$59.1K |
| 2 |
Renaissance Technologies
New York
|
+$29.6K |
| 3 |
GS
GTS Securities
New York
|
+$19.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.46K |
| 5 |
Goldman Sachs
New York
|
+$5.1K |
